Med-tech and health facilities: A cybersecurity house of mirrors
While the average cost of a data breach surpassed $9 million in 2021, the calculation for a widespread cyber-physical attack in the healthcare industry remains...
Dan Price, CEO who cut his pay so workers earned $70,000, quits amid legal woes
A Seattle CEO who announced in 2015 that he was giving himself a drastic pay cut to help cover the cost of big raises for...
Breaking down the U.S. economy’s mixed signals
Breaking down the U.S. economy's mixed signals - CBS News Watch CBS News Unemployment is down. Inflation is up. With the Federal Reserve Board again...
Saturday Sessions: Death Cab For Cutie performs “Here to Forever”
Saturday Sessions: Death Cab For Cutie performs “Here to Forever” - CBS News Watch CBS News The Seattle, Washington-based indie rock band Death Cab For...
Health equity should start at birth
Those who are pregnant as well as their babies are often among the most overlooked groups in clinical research, a challenge magnified by Covid-19. Despite...
Biden returns to U.S. following trip to meet leaders in the Middle East
Biden returns to U.S. following trip to meet leaders in the Middle East - CBS News Watch CBS News President Biden is back in the...
Takeaways from seventh Jan. 6 committee hearing
Takeaways from seventh Jan. 6 committee hearing - CBS News Watch CBS News The latest Jan. 6 committee hearing focused on the role of extremist...
Health tech vendors can be the middleman that improves payer-provider relationships
It’s no secret that payers and providers have a historically antagonistic relationship. This struggle was noted in KLAS’ recent “Points of Light” report, which optimistically...
Prenatal to postpartum: Using healthcare data to improve maternal health
The maternal health crisis remains unsolved across most of the U.S. Our nation reports the highest maternal death rate of any developed country in the...
The new paradigm in drug development: Why platform technology is the solution patients and payers need
We are living in a dynamic time of drug development and innovation with many beneficiaries—the most important being the patient. These developments include everything from...